healthmedicinet
Daily News and Tips
MENU
A-Z Health Topics
Medical Conditions
Symptoms
Interactive Tools
Drugs, Supplements
Archive
October 8, 2015
Phase II psoriasis study shows efficacy of Boehringer Ingelheim’s BI 655066 over ustekinumab
news
Boehringer Ingelheim Pharmaceuticals, Inc.
←
Previous
Next
→